Literature DB >> 18598197

Relationship between human immunodeficiency type 1 infection and expression of human APOBEC3G and APOBEC3F.

Nzovu K Ulenga1, Abdoulaye Dieng Sarr, Seema Thakore-Meloni, Jean-Louis Sankalé, Geoff Eisen, Phyllis J Kanki.   

Abstract

BACKGROUND: Human immunodeficiency virus type 1 (HIV-1)-infected individuals with a high viral set point progress to acquired immunodeficiency syndrome (AIDS) more rapidly than those with a low viral set point. It is not entirely clear which host and viral factors are responsible for the viral set point. Host factors that affect virus replication are likely to influence the viral set point. Human APOBEC proteins have been shown to restrict HIV-1 replication.
METHODS: This prospective study was conducted to determine the relationship between human APOBEC3G (hA3G) and APOBEC3F (hA3F) levels and the viral set point. Fourteen subjects were classified as having a high viral set point, and 16 were classified as having a low viral set point. We quantified the levels of hA3G and hA3F mRNA in HIV-1-infected, antiretroviral drug-naive individuals before and after infection.
RESULTS: We found a significant correlation between the hA3G mRNA level and the viral set point. The expression of hA3G and hA3F increased after infection, and the levels of hA3G and hA3F mRNA were significantly higher after infection in the low viral set point group, compared with the high viral set point group.
CONCLUSIONS: The results suggest that the level of hA3G expression affects the establishment of the viral set point and may therefore function as a host determinant in the pathogenesis of HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18598197     DOI: 10.1086/590212

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  29 in total

Review 1.  Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.

Authors:  Belete A Desimmie; Krista A Delviks-Frankenberrry; Ryan C Burdick; DongFei Qi; Taisuke Izumi; Vinay K Pathak
Journal:  J Mol Biol       Date:  2013-11-02       Impact factor: 5.469

2.  Accessory genes confer a high replication rate to virulent feline immunodeficiency virus.

Authors:  Ryan M Troyer; Jesse Thompson; John H Elder; Sue VandeWoude
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

3.  Identification of two APOBEC3F splice variants displaying HIV-1 antiviral activity and contrasting sensitivity to Vif.

Authors:  Kara G Lassen; Silke Wissing; Michael A Lobritz; Mario Santiago; Warner C Greene
Journal:  J Biol Chem       Date:  2010-07-12       Impact factor: 5.157

4.  APOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4+ T-cell counts and plasma viral load.

Authors:  Kavidha Reddy; Cheryl A Winkler; Lise Werner; Koleka Mlisana; Salim S Abdool Karim; Thumbi Ndung'u
Journal:  AIDS       Date:  2010-01-16       Impact factor: 4.177

5.  Increased expression with differential subcellular location of cytidine deaminase APOBEC3G in human CD4(+) T-cell activation and dendritic cell maturation.

Authors:  Harold Oliva; Rodrigo Pacheco; José M Martinez-Navio; Marta Rodríguez-García; Mar Naranjo-Gómez; Núria Climent; Carolina Prado; Cristina Gil; Montserrat Plana; Felipe García; José M Miró; Rafael Franco; Francesc E Borras; Naveenan Navaratnam; José M Gatell; Teresa Gallart
Journal:  Immunol Cell Biol       Date:  2016-03-18       Impact factor: 5.126

6.  Alteration of select gene expression patterns in individuals infected with HIV-1.

Authors:  Erik Serrao; Chia-Hao Wang; Toinette Frederick; Chi-Lin Lee; Patricia Anthony; David Arribas-Layton; Kerry Baker; Joshua Millstein; Andrea Kovacs; Nouri Neamati
Journal:  J Med Virol       Date:  2014-01-30       Impact factor: 2.327

Review 7.  Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics.

Authors:  John S Albin; Reuben S Harris
Journal:  Expert Rev Mol Med       Date:  2010-01-22       Impact factor: 5.600

8.  Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections.

Authors:  Andrew E Armitage; Koen Deforche; John J Welch; Kristel Van Laethem; Ricardo Camacho; Andrew Rambaut; Astrid K N Iversen
Journal:  J Virol       Date:  2014-08-27       Impact factor: 5.103

9.  Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets.

Authors:  Fransje A Koning; Edmund N C Newman; Eun-Young Kim; Kevin J Kunstman; Steven M Wolinsky; Michael H Malim
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

10.  APOBEC3G expression and hypermutation are inversely associated with human immunodeficiency virus type 1 (HIV-1) burden in vivo.

Authors:  Yordanka Kourteva; MariaPia De Pasquale; Tara Allos; Chara McMunn; Richard T D'Aquila
Journal:  Virology       Date:  2012-05-12       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.